Globally, women continue to face systemic challenges in healthcare, with UN data showing they are less likely to be taken seriously, accurately diagnosed, or properly treated. Misdiagnosis, delayed care, and entrenched medical bias persist, undermining women’s health, safety, and quality of life. Despite healthcare being a fundamental human right, inequalities remain widespread, affecting day-to-day access and outcomes.
Women’s pain and symptoms are often dismissed or misinterpreted, reflecting a medical system historically designed around male physiology. This bias is embedded in clinical tools, research priorities, and treatment protocols, with real consequences for women’s wellbeing. Outdated diagnostic instruments, such as the pelvic speculum, highlight how clinical practices have evolved little to prioritize women’s comfort, dignity, or safety.
Some progress has been made over the past two decades. Maternal mortality declined by 40% between 2000 and 2023, adolescent fertility rates fell, skilled birth attendance increased, and the use of modern family planning methods rose. However, these gains are uneven. In the least developed countries, adolescent births have actually increased, and women continue to live longer than men—on average 3.8 years more—but spend more years in poor health, including suffering from chronic conditions such as musculoskeletal disorders, gynecological diseases, migraines, and depression.
Research and funding gaps persist for conditions that primarily affect women. Premenstrual syndrome, endometriosis, and autoimmune diseases are often underfunded and under-researched. Delays in diagnosis are common, with endometriosis taking four to twelve years on average to identify. Historically, women were excluded from clinical trials until 1993, meaning many treatments were developed using male biology, leading to higher rates of adverse drug reactions and misinterpreted symptoms. Emerging technologies, including AI, still often underrepresent women in medical datasets.
Healthcare disparities also arise from underrepresentation of women in leadership roles. Female doctors and leaders are more likely to prioritize patient-centered care, improve evidence-based practices, and shape policies that enhance women’s health outcomes. Conditions such as heart disease further illustrate gendered gaps, as widely recognized symptoms are based on male presentations, leaving women at greater risk of delayed diagnosis and higher mortality.
Addressing these challenges requires healthcare systems that better reflect women’s realities. This includes more inclusive research, improved diagnostic tools, recognition of sex- and gender-specific symptoms, and stronger leadership by women in medicine and policy. Doing so can reduce misdiagnosis, improve treatment outcomes, and ensure that women not only live longer but also experience better health and quality of life.
